Literature DB >> 468513

Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation.

C Y Pak, K Holt, J E Zerwekh.   

Abstract

The interaction between mucopolysaccharide (glycosaminoglycans) and monosodium urate, with respect to their effects on spontaneous precipitation of calcium oxalate, was explored in vitro. Heparin and, to a lesser extent, chondroitin sulfate were found to inhibit calcium oxalate precipitation. The formation product ratio (FPR, limit of metastability or the minimum supersaturation required for spontaneous nucleation) of calcium oxalate was increased 29 per cent by 0.05 mg of heparin per liter, and by 70 per cent with 1 mg of heparin per liter. The increment produced by heparin was much less pronounced when the solution containing the mucopolysaccharide was preincubated with crystalline monosodium urate. Pretreatment of the solution containing heparin (0.05 mg per liter) by monosodium urate (0.5 mg per ml) virtually eliminated the inhibitory action of heparin. Studies with radioactive heparin indicated that monosodium urate binds heparin. In contrast, the inhibitory effect of chondroitin sulfate was unaltered by prior exposure to monosodium urate. The results indicated that monosodium urate may attenuate the inhibitor activity of certain mucopolysaccharides such as heparin and facilitate the calcium oxalate precipitation. The findings provide further support for the important etiologic role of hyperuricosuria in the formation of calcium oxalate stones.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468513

Source DB:  PubMed          Journal:  Invest Urol        ISSN: 0021-0005


  12 in total

Review 1.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  The effects of glycosaminoglycans, pyrophosphate and allopurinol treatment on urease-induced crystallization in vitro.

Authors:  H Hedelin; L Grenabo; S Pettersson
Journal:  Urol Res       Date:  1986

Review 3.  Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.

Authors:  R L Ryall
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

4.  Texture examinations on grain and thin section preparations of calcium oxalate calculi and their relations to pathogenetic parameters.

Authors:  G Schubert; G Brien; S Lenk; R Koch
Journal:  Urol Res       Date:  1983

5.  Risk factors associated to kidney stones in primary hyperparathyroidism.

Authors:  S Corbetta; A Baccarelli; A Aroldi; L Vicentini; G B Fogazzi; C Eller-Vainicher; C Ponticelli; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

6.  Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.

Authors:  D Senthil; K Subha; N Saravanan; P Varalakshmi
Journal:  Mol Cell Biochem       Date:  1996-03-09       Impact factor: 3.396

7.  Effects of sodium urate and uric acid crystals on the crystallization of calcium oxalate.

Authors:  H G Tiselius
Journal:  Urol Res       Date:  1984

8.  Glycosaminoglycans, uric acid and calcium oxalate urolithiasis.

Authors:  F Grases; A Costa-Bauzá; J G March; L Masárová
Journal:  Urol Res       Date:  1991

9.  Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization.

Authors:  F Atmani; B Lacour; T Drüeke; M Daudon
Journal:  Urol Res       Date:  1993-01

10.  Urinary excretion of urate in patients with calcium oxalate stone disease.

Authors:  H G Tiselius; L Larsson
Journal:  Urol Res       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.